Copy Number
The putative cancer-associated PDGs driven by SCNAs in each cancer type were identified by four criteria: 1) located in a peak region of a significantly recurrent focal SNCA locus estimated by the genomic identification of significant targets in cancer (GISTIC2) algorithm, (q≤0.25); 2) altered with high frequency and large amplitude (G-score ≥0.1); 3) mRNA reliably detected in at least 10% of tumor specimens in the given cancer type (90th percentile of FPKM value ≥1); and 4) mRNA significantly and positively correlated with copy numbers (Pearson P-value less than 0.001).
| Showing page 53 |
first page | previous page | next page | last page |
| Overall_Gscore | No. of Cancer Types | ||||
| HGNC Symbol | Ensembl Gene ID | Amplification | Deletion | Amplification | Deletion |
| MTNR1B | ENSG00000134640 | 0.00 | 0.00 | 0 | 0 |
| YARS | ENSG00000134684 | 0.00 | 0.00 | 0 | 0 |
| DAGLA | ENSG00000134780 | 0.00 | 0.18 | 0 | 1 |
| SLC43A3 | ENSG00000134802 | 0.00 | 0.00 | 0 | 0 |
| GIF | ENSG00000134812 | 0.00 | 0.00 | 0 | 0 |
| APLNR | ENSG00000134817 | 0.00 | 0.00 | 0 | 0 |
| C5AR2 | ENSG00000134830 | 0.00 | 0.00 | 0 | 0 |
| ERCC5 | ENSG00000134899 | 0.68 | 0.00 | 4 | 0 |
| TPP2 | ENSG00000134900 | 0.69 | 0.00 | 4 | 0 |
| ADAMTS8 | ENSG00000134917 | 0.00 | 0.00 | 0 | 0 |
| SLC37A2 | ENSG00000134955 | 0.00 | 0.00 | 0 | 0 |
| CTSL | ENSG00000135047 | 0.00 | 0.00 | 0 | 0 |
| CSN2 | ENSG00000135222 | 0.00 | 0.00 | 0 | 0 |
| UGT2B28 | ENSG00000135226 | 0.00 | 0.00 | 0 | 0 |
| HILPDA | ENSG00000135245 | 0.11 | 0.14 | 1 | 1 |
| HTR1B | ENSG00000135312 | 0.00 | 0.00 | 0 | 0 |
| CD63 | ENSG00000135404 | 0.00 | 0.00 | 0 | 0 |
| LACRT | ENSG00000135413 | 0.00 | 0.00 | 0 | 0 |
| RDH5 | ENSG00000135437 | 0.00 | 0.00 | 0 | 0 |
| CDK4 | ENSG00000135446 | 2.79 | 0.00 | 6 | 0 |
|
Showing page 53 |
first page | previous page | next page | last page |
Copyright © 2020 University of Pennsylvania. All Rights Reserved.